The efficacy of daclizumab for intestinal transplantation: Preliminary report

Transplantation Proceedings

Volumn 32, Issue 6, 2000, Pages 1195-1196

  Abu Elmagd, K ^a   Fung, J ^a   McGhee, W ^a   Martin, D ^a   Mazariegos, G ^a   Schaefer, N ^a   Demetris, J ^a   Starzl, T E ^a   Reyes, J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3;

CLINICAL ARTICLE; CONFERENCE PAPER; CYTOMEGALOVIRUS; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; ANTIBODIES, MONOCLONAL; CHILD; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033835561     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01180-5     Document Type: Article

References (6)

1. Abu-Elmagd K., Reyes J., Todo S., et al. J Am Coll Surg. 186:1998;512.
2. Vincenti F., Kirkman R., Light S., et al. N Engl J Med. 338:1998;161.
3. Starzl T.E., Todo S., Tzakis A., et al. Surg Gynecol Obstet. 172:1991;335.
4. Abu-Elmagd K., Todo S., Tzakis A., et al. Surg Gynecol Obstet. 179:1994;385.
5. Fontes P., Rao A., Demetris A.J., et al. Lancet. 344:1994;151.
6. Lee R.G., Nakamura K., Tsamandas A.C., et al. Gastroenterology. 110:1996;1820.